Biotech Innovent Dosed First Participant in Phase 3 Clinical Study (GLORY-2) of Mazdutide (IBI362) Higher Dose 9 mg in Chinese Adults with Obesity January 2, 2024
Biotech FDA Keynote Speaker in the Spotlight, CAR-T Industry Leaders Gather for Discussion-Join the 2024 GenScript Biotech Global Forum for a New Journey in Cell and Gene Therapy December 26, 2023
Biotech Jemincare Announces 6 Approvals of Clinical Trials for its Innovative Drugs December 26, 2023
Biotech PharmaBlock Obtained ISO 50001 Certification, Advancing Sustainable Development December 26, 2023
Biotech Harbin City Pushes for Breakthroughs in Full Revitalization of Northeast China December 26, 2023
Biotech Biocytogen Enters into Antibody Agreement with Ona Therapeutics to Develop Antibody-Drug Conjugates Targeting Solid Tumors December 18, 2023
Biotech GC Biopharma Announces US FDA Approval for ALYGLO™ (Immune Globulin Intravenous, Human-stwk) 10% Liquid for Adults with Primary Humoral Immunodeficiency (PI) December 18, 2023
Biotech Transcenta Announces the Publication of Preclinical Results of [177Lu]Lu-TST001 Radionuclide Antibody Conjugate as Potential Novel Treatment Option for Metastatic Gastric Cancer in the European Journal of Nuclear Medicine and Molecular Imaging December 13, 2023